Concepedia

Bo Mi Ku

BM

45

Publications

3.7K

Citations

28

H-Index

2006

Active since

Affiliations

Samsung Medical Center(Current)

Sungkyunkwan University

Samsung (South Korea)

Gyeongsang National University

Korea Advanced Institute of Science and Technology

Bo Mi Ku is an author at Samsung Medical Center specializing in medicine, cancer research, and tumor biology.

ORCID

Top concepts

Publications per year

2006–2023

45

Publications

45

Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma

Nayoung Kim, Hong Kwan Kim, Kyungjong Lee et al. · Nature Communications · 2020 · 1.3K citations · Full text

, , +20

Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial

Jinhyun Cho, Hae Su Kim, Bo Mi Ku et al. · Journal of Clinical Oncology · 2018 · 330 citations · Full text

The First-week Proliferative Response of Peripheral Blood PD-1+CD8+ T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors

Kyung Hwan Kim, Jinhyun Cho, Bo Mi Ku et al. · Clinical Cancer Research · 2019 · 201 citations · Full text

Caffeine-Mediated Inhibition of Calcium Release Channel Inositol 1,4,5-Trisphosphate Receptor Subtype 3 Blocks Glioblastoma Invasion and Extends Survival

Sang Soo Kang, Kyung‐Seok Han, Bo Mi Ku et al. · Cancer Research · 2010 · 184 citations · Full text

, , +17

CHI3L1 (YKL‐40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells

Bo Mi Ku, Yeon Kyung Lee, Jinhyun Ryu et al. · International Journal of Cancer · 2010 · 118 citations · Full text

Rows per page

1–5 of 45